WallStreetZenWallStreetZen

NASDAQ: ASTH
Astrana Health Inc Stock

$45.00+6.80 (+17.8%)
Updated Jul 11, 2024
ASTH Price
$45.00
Fair Value Price
$88.96
Market Cap
$2.52B
52 Week Low
$28.87
52 Week High
$45.71
P/E
34.09x
P/B
3.86x
P/S
1.6x
PEG
2.67x
Dividend Yield
N/A
Revenue
$1.45B
Earnings
$62.42M
Gross Margin
16.6%
Operating Margin
7.91%
Profit Margin
4.3%
Debt to Equity
1.18
Operating Cash Flow
$66M
Beta
1.21
Next Earnings
Aug 5, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ASTH Overview

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ASTH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ASTH ($45.00) is undervalued by 49.42% relative to our estimate of its Fair Value price of $88.96 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ASTH ($45.00) is significantly undervalued by 49.42% relative to our estimate of its Fair Value price of $88.96 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ASTH ($45.00) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ASTH due diligence checks available for Premium users.

Be the first to know about important ASTH news, forecast changes, insider trades & much more!

ASTH News

Valuation

ASTH fair value

Fair Value of ASTH stock based on Discounted Cash Flow (DCF)
Price
$45.00
Fair Value
$88.96
Undervalued by
49.42%
ASTH ($45.00) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ASTH ($45.00) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ASTH ($45.00) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ASTH price to earnings (PE)

For valuing profitable companies with steady earnings
Company
34.09x
Industry
37.57x
Market
31.84x
ASTH is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ASTH is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

ASTH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.86x
Industry
4.59x
ASTH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ASTH price to earnings growth (PEG)

For valuing profitable companies with growth potential
ASTH is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

ASTH's financial health

Profit margin

Revenue
$404.4M
Net Income
$14.8M
Profit Margin
3.7%
ASTH's Earnings (EBIT) of $115.05M... subscribe to Premium to read more.
Interest Coverage Financials
ASTH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.2B
Liabilities
$773.9M
Debt to equity
1.18
ASTH's short-term assets ($538.81M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ASTH's short-term assets ($538.81M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ASTH's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ASTH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$6.0M
Investing
-$71.0M
Financing
$106.4M
ASTH's operating cash flow ($66.48M)... subscribe to Premium to read more.
Debt Coverage Financials

ASTH vs Medical Care Facility Stocks

TickerMarket Cap1d %P/EP/B
ASTH$2.52B+17.80%34.09x3.86x
AGL$2.53B+9.04%-8.91x3.67x
LFST$2.10B+8.93%-11.44x1.47x
ADUS$1.96B+0.84%29.21x2.70x
AMN$1.87B+4.89%13.08x2.19x

Astrana Health Stock FAQ

What is Astrana Health's quote symbol?

(NASDAQ: ASTH) Astrana Health trades on the NASDAQ under the ticker symbol ASTH. Astrana Health stock quotes can also be displayed as NASDAQ: ASTH.

If you're new to stock investing, here's how to buy Astrana Health stock.

What is the 52 week high and low for Astrana Health (NASDAQ: ASTH)?

(NASDAQ: ASTH) Astrana Health's 52-week high was $45.71, and its 52-week low was $28.87. It is currently -1.56% from its 52-week high and 55.9% from its 52-week low.

How much is Astrana Health stock worth today?

(NASDAQ: ASTH) Astrana Health currently has 56,025,538 outstanding shares. With Astrana Health stock trading at $45.00 per share, the total value of Astrana Health stock (market capitalization) is $2.52B.

Astrana Health stock was originally listed at a price of $10.00 in Dec 8, 2017. If you had invested in Astrana Health stock at $10.00, your return over the last 6 years would have been 350%, for an annualized return of 28.49% (not including any dividends or dividend reinvestments).

How much is Astrana Health's stock price per share?

(NASDAQ: ASTH) Astrana Health stock price per share is $45.00 today (as of Jul 11, 2024).

What is Astrana Health's Market Cap?

(NASDAQ: ASTH) Astrana Health's market cap is $2.52B, as of Jul 12, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Astrana Health's market cap is calculated by multiplying ASTH's current stock price of $45.00 by ASTH's total outstanding shares of 56,025,538.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.